Vise Technologies, Inc.
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1812090
NEW YORK, NY
Position in TEVA
as of Mar 31, 2026
· filed Apr 21, 2026
Position Value
$633,423
-$22,923 QoQ
Shares Held
21,030
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Vise Technologies, Inc. holds $6,566,816 across 15 Drug Manufacturers - Specialty & Generic names. TEVA ranks #3 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
96,317 | $1,783,790 | |
| 2 | ZTS |
Zoetis Inc.
|
5,362 | $633,842 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
21,030 | $633,423 | |
| 4 | HLN |
Haleon plc
|
61,998 | $620,599 | |
| 5 | PBH |
Prestige Consumer Healthcare Inc.
|
8,098 | $479,968 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
790 | $468,454 | |
| 7 | VTRS |
Viatris Inc
|
30,669 | $414,338 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
23,603 | $326,901 |
All Filings in TEVA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $633,423 | 21,030 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $656,346 | 21,030 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $390,466 | 19,330 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $326,384 | 19,474 | Shares | Sole | 2025-08-07 | |
| 2024-12-31 | $292,845 | 13,287 | Shares | Sole | 2025-02-18 | |
| No filing history on record for this holder in this stock. | ||||||